145 related articles for article (PubMed ID: 33407592)
1. PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer.
Du L; Gao Y
J Transl Med; 2021 Jan; 19(1):12. PubMed ID: 33407592
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
Liu W; Liu P; Gao H; Wang X; Yan M
Mol Oncol; 2020 Oct; 14(10):2660-2677. PubMed ID: 32412676
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs PGM5-AS1 upregulates Decorin (DCN) to inhibit cervical cancer progression by sponging miR-4284.
Wang H; Wang D; Wei Q; Li C; Li C; Yang J
Bioengineered; 2022 Apr; 13(4):9872-9884. PubMed ID: 35420507
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PGM5-AS1 Inhibits the Progression of Bladder Cancer by Regulating miR-587/SLIT3 Axis.
Duan X; Wang L; Wang Z; Wei W; Wang M; Ding D
Crit Rev Eukaryot Gene Expr; 2022; 32(8):9-22. PubMed ID: 36017912
[TBL] [Abstract][Full Text] [Related]
6. p53-induced long non-coding RNA PGM5-AS1 inhibits the progression of esophageal squamous cell carcinoma through regulating miR-466/PTEN axis.
Zhihua Z; Weiwei W; Lihua N; Jianying Z; Jiang G
IUBMB Life; 2019 Oct; 71(10):1492-1502. PubMed ID: 31185143
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.
Zhang Q; Ding Z; Wan L; Tong W; Mao J; Li L; Hu J; Yang M; Liu B; Qian X
Cancer Biol Ther; 2020; 21(2):157-169. PubMed ID: 31619123
[TBL] [Abstract][Full Text] [Related]
8. Reduced long noncoding RNA PGM5-AS1 facilitated proliferation and invasion of colorectal cancer through sponging miR-100-5p.
Zhou B; Yi F; Chen Y; Li CH; Cheng YS; Yang K
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7972-7981. PubMed ID: 32767323
[TBL] [Abstract][Full Text] [Related]
9. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p.
Luo JF; Xu J; Zheng JZ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7816-7825. PubMed ID: 31599406
[TBL] [Abstract][Full Text] [Related]
11. Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis.
Liu B; Jiang HY; Yuan T; Zhou WD; Xiang ZD; Jiang QQ; Wu DL
Curr Pharm Des; 2021; 27(41):4261-4269. PubMed ID: 34126893
[TBL] [Abstract][Full Text] [Related]
12. The Downregulation of lncRNA
Shen Y; Qi L; Li Y; Zhang Y; Gao X; Zhu Y; Wang K
Cancer Biother Radiopharm; 2021 Mar; 36(2):220-229. PubMed ID: 32354224
[No Abstract] [Full Text] [Related]
13. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
14. Long non-coding RNA ADAMTS9-AS1 inhibits the progression of prostate cancer by modulating the miR-142-5p/CCND1 axis.
Zhou Z; Wu X; Zhou Y; Yan W
J Gene Med; 2021 May; 23(5):e3331. PubMed ID: 33704879
[TBL] [Abstract][Full Text] [Related]
15. Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer.
Hui B; Lu C; Wang J; Xu Y; Yang Y; Ji H; Li X; Xu L; Wang J; Tang W; Wang K; Gu Y
J Cell Physiol; 2022 Jan; 237(1):911-933. PubMed ID: 34463962
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
18. FOXD1-AS1 promotes malignant behaviours of prostate cancer cells via the miR-3167/YWHAZ axis.
Qu W; Wei X; Zhang H; Hou J
Andrologia; 2022 Feb; 54(1):e14263. PubMed ID: 34674391
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA NUTM2A-AS1/miR-376a-3p/PRMT5 Axis Promotes Prostate Cancer Progression.
Han H; Li Z; Bi L; Zhang J
Arch Esp Urol; 2024 Mar; 77(2):173-182. PubMed ID: 38583010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
